-

BioTek reMEDys Celebrates the Work of Collaborating Healthcare Professionals During National Interprofessional Healthcare Month

NEW CASTLE, Del.--(BUSINESS WIRE)--In recognition of National Interprofessional Healthcare Month, BioTek reMEDys, a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases, is publicly calling for awareness of safe medication use for patients with rare diseases and conditions, while celebrating the critical contributions and collaborative spirit of healthcare professionals nationwide, applauding the efforts of those who impact the patient experience every day.

National Interprofessional Healthcare Month is observed annually each April. It aims to promote collaboration and communication among healthcare professionals from various disciplines, such as medicine, nursing, pharmacy, and social work. The month highlights the importance of interprofessional healthcare teams in providing high-quality, patient-centered care. It encourages healthcare providers to work together effectively, share knowledge, and improve patient outcomes overall.

To participate this year, BioTek is proactively promoting the observance among patients, patient loved ones, colleagues, pharmacists, hospitals, health centers, and other groups working together to integrate and expand the mission of improving patient treatment experiences.

“As an infusion therapy provider organization focused on the highly specific needs of patients living with rare conditions, we are particularly grateful to all the hard working professionals across the healthcare continuum who go out of their way to positively impact the wellbeing of the patients we serve,” said Chai Gadde, CEO and founder of BioTek reMEDys. “While it’s something we focus on year round, National Interprofessional Healthcare Month is a time to recognize the powerful impact health professionals – who we proudly work alongside as colleagues on a daily basis – have on the patient population, and on the healthcare system as a whole. We are passionate about shining a spotlight on those who day in and day out ensure that treatments, medications and communication are safe, compassionate and appropriate so that patients are achieving optimal outcomes.”

“When multiple health workers from different professional backgrounds and disciplines work together with patients, families, care-givers, and communities to collaboratively work toward delivering the highest quality care, better health outcomes for all can be achieved,” added Gadde.

BioTek reMEDys is a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases. Through supply chain management, innovative technology and trained specialty pharmacists, BioTek reMEDys is able to deliver superior service at a lower cost. The company bridges the gap between managed care, physicians and patients by facilitating the authorization, procurement and administration of specialty medications and infusions. BioTek reMEDys provides high-touch therapies, biologics and pharmaceuticals to support treatment for patients with rare diseases and chronic conditions, ensuring the highest quality of care. For information visit www.biotekrx.com.

Contacts

Media Contact:
Paul Williams
paul@medialinecommunications.com
310/569-0023

BioTek reMEDys


Release Versions

Contacts

Media Contact:
Paul Williams
paul@medialinecommunications.com
310/569-0023

Social Media Profiles
More News From BioTek reMEDys

BioTek reMEDys Encourages Education and Awareness for Autoinflammatory Conditions

NEW CASTLE, Del.--(BUSINESS WIRE)--BioTek reMEDys, a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases, is publicly calling for year-round enhanced education and awareness of these rare diseases and conditions. Autoinflammatory diseases refer to problems with the innate immune system’s reactions. Immune cells target the body’s own healthy tissues by mistake, signaling the body to attack them. This can cause intense episodes of inf...

BioTek reMEDys Names Neal Fitzpatrick Chief Strategy Officer

NEW CASTLE, Del.--(BUSINESS WIRE)--BioTek reMEDys, a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases, has named Neal C. Fitzpatrick as its Chief Strategy Officer. Fitzpatrick recently served as Chief Commercial Officer at a biotech company, charged with leading the organization through a period of high growth. Before this, he served as Vice-President of Sales at ADMA Biologics, where he repositioned an essential product from hos...

BioTek reMEDys Celebrates the Work of Pharmacy Professionals for American Pharmacists Month

NEW CASTLE, Del.--(BUSINESS WIRE)--In honor of October being American Pharmacists Month, BioTek reMEDys, a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases, is calling for enhanced education and awareness of safe medication use for patients with rare diseases and conditions, while also celebrating and drawing attention to the vital role and invaluable contributions of pharmacists nationwide. Annually celebrated during the month o...
Back to Newsroom